Bupa today announces that, subject to regulatory approval, Don Robert will be appointed to the Board as a Non-Executive Director in February 2025 and, following a period of handover, will succeed Roger Davis as Chair of Bupa in May 2025.
Cath Keers, Senior Independent Director, who led the Chair Selection Committee of the Bupa Board, said: “We have carried out a thorough global search process to identify a successor to Roger Davis, who will be retiring as Chairman of Bupa next year after more than nine years as a member of the Board. We are pleased to announce that, subject to regulatory approval, Don Robert will join the Board and become Chair of the Group next year. Don has a deep understanding of financial services, technology and data as well as significant Board-level experience at a range of international companies.
“On behalf of the Board, I would like to thank Roger for his outstanding leadership and contribution to Bupa since his appointment as Chairman in January 2019. He led the Board through the COVID-19 pandemic, spearheaded the Group’s humanitarian response to the war in Ukraine, and has supported the leadership team in transforming Bupa into an organisation which is focused on becoming the world’s most customer-centric healthcare company. We wish him well for the future.”
Roger Davis
Roger Davis, Bupa Chairman, said: “I have been honoured to serve as Chairman of Bupa since 2019 and I am delighted to welcome Don to the Board as my successor. His outstanding experience will provide the Board with the leadership required to support the continued transformation of the Group.
“I’m proud of the significant strategic progress Bupa has made during my time as Chairman, combined with improved financial performance and a strong focus on delivering the best experience for our customers. I would like to thank everyone at Bupa for their hard work, care and commitment, which has provided the strong foundations for our success as an organisation. With Don as Chair, I’m confident that Bupa will go from strength to strength under the continued leadership of Iñaki Ereño as CEO.”
Don Robert
Don Robert said: “I am looking forward to joining Bupa’s Board and then taking on the role of Chair when Roger Davis steps down. I hope to continue Roger’s work, alongside Iñaki and his executive team, in delivering Bupa’s strategy and supporting the business to achieve its ambition of being the world’s most customer-centric healthcare company.”
Notes to Editors
Don Robert biography
Don Robert is currently Chair of the London Stock Exchange Group plc and Chair of Council at the London School of Hygiene and Tropical Medicine. He is a founding partner at Corten Capital, a specialist information and software investment firm, and a non-executive director at Validis Holdings plc, a financial accounting software company, and Flex Factor, a fintech company specialising in failed online payment recovery. Don is the former Chief Executive and Chair of the global financial data, analytics and technology group, Experian plc, the former Chairman of the video games services company, Keywords Studios plc, and served as a Member of the Court of Directors of the Bank of England from 2014 until 2019.
About Bupa
Established in 1947, Bupa's purpose is helping people live longer, healthier, happier lives and making a better world. We are an international healthcare company serving over 50 million customers worldwide. With no shareholders, we reinvest profits into providing more and better healthcare for the benefit of current and future customers. Bupa has businesses around the world, principally in the UK, Australia, Spain, Chile, Poland, New Zealand, Hong Kong SAR, Türkiye, Brazil, Mexico and India. We also have associate businesses in Saudi Arabia.
Enquiries
Duncan West: [email protected]
